126 related articles for article (PubMed ID: 24698419)
61. Lymphomatous polyposis of the gastrointestinal tract, including mantle cell lymphoma, follicular lymphoma and mucosa-associated lymphoid tissue lymphoma.
Kodama T; Ohshima K; Nomura K; Taniwaki M; Nakamura N; Nakamura S; Kohno S; Yamamoto J; Karube K; Yamasita Y; Shirakusa T; Kikuchi M
Histopathology; 2005 Nov; 47(5):467-78. PubMed ID: 16241994
[TBL] [Abstract][Full Text] [Related]
62. The 3q27 and 18q21 translocations for follicular lymphoma and diffuse large B-cell lymphoma in the rituximab era.
Watanabe R; Tomita N; Matsumoto C; Hattori Y; Matsuura S; Takasaki H; Hashimoto C; Fujita H; Fujisawa S; Ishigatsubo Y
J Clin Exp Hematop; 2013; 53(2):107-14. PubMed ID: 23995106
[TBL] [Abstract][Full Text] [Related]
63. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.
Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T
Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669
[TBL] [Abstract][Full Text] [Related]
64. Characteristics of CD5-positive splenic marginal zone lymphoma with leukemic manifestation ; clinical, flow cytometry, and histopathological findings of 11 cases.
Kojima M; Sato E; Oshimi K; Murase T; Koike T; Tsunoda S; Matsumoto T; Marutsuka K; Ogiya D; Moriuchi M; Tokunaka M; Yara Kikuti Y; Kikuchi T; Nakamura N; Ando K
J Clin Exp Hematop; 2010; 50(2):107-12. PubMed ID: 21123968
[TBL] [Abstract][Full Text] [Related]
65. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.
Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
[TBL] [Abstract][Full Text] [Related]
66. Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.
Stoos-Veić T; Livun A; Ajduković R; Pejsa V; Jaksić O; Kusec R
Coll Antropol; 2010 Jun; 34(2):425-9. PubMed ID: 20698113
[TBL] [Abstract][Full Text] [Related]
67. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes.
Horsman DE; Okamoto I; Ludkovski O; Le N; Harder L; Gesk S; Siebert R; Chhanabhai M; Sehn L; Connors JM; Gascoyne RD
Br J Haematol; 2003 Feb; 120(3):424-33. PubMed ID: 12580956
[TBL] [Abstract][Full Text] [Related]
68. Gastrointestinal follicular lymphoma: using primary site as a predictor of survival.
Chouhan J; Batra S; Gupta R; Guha S
Cancer Med; 2016 Oct; 5(10):2669-2677. PubMed ID: 27696758
[TBL] [Abstract][Full Text] [Related]
69. Sensitivity and reproducibility of conventional qualitative and quantitative PCR assays for detection of the t(14;18)(q32;q21) chromosomal translocation in biopsy material from patients with follicular lymphoma.
Kokovic I; Novakovic BJ; Grazio SF; Novakovic S
Int J Mol Med; 2009 Jan; 23(1):9-15. PubMed ID: 19082502
[TBL] [Abstract][Full Text] [Related]
70. Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection.
Zelenetz AD; Chen TT; Levy R
J Exp Med; 1992 Oct; 176(4):1137-48. PubMed ID: 1402658
[TBL] [Abstract][Full Text] [Related]
71. Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes.
Henopp T; Quintanilla-Martínez L; Fend F; Adam P
Histopathology; 2011 Jul; 59(1):139-42. PubMed ID: 21771030
[TBL] [Abstract][Full Text] [Related]
72. CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features.
Karube K; Guo Y; Suzumiya J; Sugita Y; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Takeshita M; Kikuchi M; Nakamura N; Takasu O; Arakawa F; Tagawa H; Seto M; Ohshima K
Blood; 2007 Apr; 109(7):3076-9. PubMed ID: 17138820
[TBL] [Abstract][Full Text] [Related]
73. Variation in BCL2 protein expression in follicular lymphomas without t(14;18) chromosomal translocations.
Masir N; Jones M; Abdul-Rahman F; Florence CS; Mason DY
Pathology; 2012 Apr; 44(3):228-33. PubMed ID: 22406486
[TBL] [Abstract][Full Text] [Related]
74. The pattern and frequency of t(14;18) translocation and immunophenotype in Asian follicular lymphoma.
Peh SC; Shaminie J; Tai YC; Tan J; Gan SS
Histopathology; 2004 Nov; 45(5):501-10. PubMed ID: 15500654
[TBL] [Abstract][Full Text] [Related]
75. Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variant.
Mohamed AN; Palutke M; Eisenberg L; Al-Katib A
Cancer Genet Cytogenet; 2001 Apr; 126(1):45-51. PubMed ID: 11343778
[TBL] [Abstract][Full Text] [Related]
76. The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas.
Adam P; Baumann R; Schmidt J; Bettio S; Weisel K; Bonzheim I; Fend F; Quintanilla-Martínez L
Hum Pathol; 2013 Sep; 44(9):1817-26. PubMed ID: 23642737
[TBL] [Abstract][Full Text] [Related]
77. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.
Murase T; Yamaguchi M; Suzuki R; Okamoto M; Sato Y; Tamaru J; Kojima M; Miura I; Mori N; Yoshino T; Nakamura S
Blood; 2007 Jan; 109(2):478-85. PubMed ID: 16985183
[TBL] [Abstract][Full Text] [Related]
78. [Clinical significance of detecting strong bcl-2 protein expression with flow cytometry in follicular lymphoma].
Kobayashi S; Motomura S; Kishi Y; Hashimoto C; Maruta A; Kodama F
Rinsho Ketsueki; 2004 Jul; 45(7):530-8. PubMed ID: 15359912
[TBL] [Abstract][Full Text] [Related]
79. SNP analysis of minimally evolved t(14;18)(q32;q21)-positive follicular lymphomas reveals a common copy-neutral loss of heterozygosity pattern.
Cheung KJ; Rogic S; Ben-Neriah S; Boyle M; Connors JM; Gascoyne RD; Horsman DE
Cytogenet Genome Res; 2012; 136(1):38-43. PubMed ID: 22104078
[TBL] [Abstract][Full Text] [Related]
80. EZH2 Expression in Follicular Lymphoma Is Variable and Independent from the Progression of Disease Within 24 Months of First Treatment.
Szumera-CieĆkiewicz A; Poleszczuk J; Paszkiewicz-Kozik E; Rymkiewicz G; SokÓŁ K; Borysiuk A; Kotarska M; Owczarek D; Kawecka M; Pytlak B; Walewski J; Prochorec-Sobieszek M
Anticancer Res; 2020 Dec; 40(12):6685-6697. PubMed ID: 33288562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
